159 related articles for article (PubMed ID: 18396386)
1. Are metabolic indices different between drug-naïve first-episode psychosis patients and healthy controls?
Sengupta S; Parrilla-Escobar MA; Klink R; Fathalli F; Ying Kin Ng ; Stip E; Baptista T; Malla A; Joober R
Schizophr Res; 2008 Jul; 102(1-3):329-36. PubMed ID: 18396386
[TBL] [Abstract][Full Text] [Related]
2. The comparison of glycometabolism parameters and lipid profiles between drug-naïve, first-episode schizophrenia patients and healthy controls.
Wu X; Huang Z; Wu R; Zhong Z; Wei Q; Wang H; Diao F; Wang J; Zheng L; Zhao J; Zhang J
Schizophr Res; 2013 Oct; 150(1):157-62. PubMed ID: 23998954
[TBL] [Abstract][Full Text] [Related]
3. Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia.
Ryan MC; Collins P; Thakore JH
Am J Psychiatry; 2003 Feb; 160(2):284-9. PubMed ID: 12562574
[TBL] [Abstract][Full Text] [Related]
4. Sex difference in effects of typical and atypical antipsychotics on glucose-insulin homeostasis and lipid metabolism in first-episode schizophrenia.
Wu RR; Zhao JP; Zhai JG; Guo XF; Guo WB
J Clin Psychopharmacol; 2007 Aug; 27(4):374-9. PubMed ID: 17632222
[TBL] [Abstract][Full Text] [Related]
5. Hyperprolactinemia and insulin resistance in drug naive patients with early onset first episode psychosis.
Petruzzelli MG; Margari M; Peschechera A; de Giambattista C; De Giacomo A; Matera E; Margari F
BMC Psychiatry; 2018 Aug; 18(1):246. PubMed ID: 30068291
[TBL] [Abstract][Full Text] [Related]
6. Relationship between insulin resistance, dyslipidaemia and positive symptom in Chinese antipsychotic-naive first-episode patients with schizophrenia.
Chen S; Broqueres-You D; Yang G; Wang Z; Li Y; Wang N; Zhang X; Yang F; Tan Y
Psychiatry Res; 2013 Dec; 210(3):825-9. PubMed ID: 24113122
[TBL] [Abstract][Full Text] [Related]
7. Impaired glucose tolerance in first-episode drug-naïve patients with schizophrenia: relationships with clinical phenotypes and cognitive deficits.
Chen DC; Du XD; Yin GZ; Yang KB; Nie Y; Wang N; Li YL; Xiu MH; He SC; Yang FD; Cho RY; Kosten TR; Soares JC; Zhao JP; Zhang XY
Psychol Med; 2016 Nov; 46(15):3219-3230. PubMed ID: 27604840
[TBL] [Abstract][Full Text] [Related]
8. Pretreatment Cardiometabolic Status in Youth With Early-Onset Psychosis: Baseline Results From the TEA Trial.
Jensen KG; Correll CU; Rudå D; Klauber DG; Stentebjerg-Olesen M; Fagerlund B; Jepsen JRM; Fink-Jensen A; Pagsberg AK
J Clin Psychiatry; 2017; 78(8):e1035-e1046. PubMed ID: 28102978
[TBL] [Abstract][Full Text] [Related]
9. Hypertriglyceridaemic waist phenotype and β-cell function in subjects with normal and impaired glucose tolerance.
Bardini G; Dicembrini I; Pala L; Cresci B; Rotella CM
Diabet Med; 2011 Oct; 28(10):1229-33. PubMed ID: 21923697
[TBL] [Abstract][Full Text] [Related]
10. Hyperglycemia and diabetes in patients with schizophrenia or schizoaffective disorders.
Cohen D; Stolk RP; Grobbee DE; Gispen-de Wied CC
Diabetes Care; 2006 Apr; 29(4):786-91. PubMed ID: 16567816
[TBL] [Abstract][Full Text] [Related]
11. Blood levels of glucose and insulin and insulin resistance in patients with schizophrenia on clozapine monotherapy.
Wysokiński A
Diabetes Metab Syndr; 2014; 8(4):236-41. PubMed ID: 25311817
[TBL] [Abstract][Full Text] [Related]
12. Parameters of glucose and lipid metabolism at the fasted state in drug-naïve first-episode patients with psychosis: Evidence for insulin resistance.
Petrikis P; Tigas S; Tzallas AT; Papadopoulos I; Skapinakis P; Mavreas V
Psychiatry Res; 2015 Oct; 229(3):901-4. PubMed ID: 26279127
[TBL] [Abstract][Full Text] [Related]
13. Pathogenic mechanism of type 2 diabetes in Ghanaians--the importance of beta cell secretion, insulin sensitivity and glucose effectiveness.
Amoah AG; Owusu SK; Schuster DP; Osei K
S Afr Med J; 2002 May; 92(5):377-84. PubMed ID: 12108171
[TBL] [Abstract][Full Text] [Related]
14. [The influence of physical training on metabolic indices in men with myocardial infarction and impaired glucose tolerance].
Stochmal A; Jasiak-Tyrkalska B; Stochmal E; Huszno B; Kawecka-Jaszcz K
Przegl Lek; 2007; 64(6):410-5. PubMed ID: 18159849
[TBL] [Abstract][Full Text] [Related]
15. Insulin resistance and metabolic profile in antipsychotic naïve schizophrenia patients.
Dasgupta A; Singh OP; Rout JK; Saha T; Mandal S
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1202-7. PubMed ID: 20600470
[TBL] [Abstract][Full Text] [Related]
16. Glucose disturbances in first-episode drug-naïve schizophrenia: Relationship to psychopathology.
Zhang XY; Chen DC; Tan YL; An HM; Zunta-Soares GB; Huang XF; Soares JC
Psychoneuroendocrinology; 2015 Dec; 62():376-80. PubMed ID: 26385108
[TBL] [Abstract][Full Text] [Related]
17. Insulin resistance, beta-cell function, and glucose tolerance in Brazilian adolescents with obesity or risk factors for type 2 diabetes mellitus.
da Silva RC; Miranda WL; Chacra AR; Dib SA
J Diabetes Complications; 2007; 21(2):84-92. PubMed ID: 17331856
[TBL] [Abstract][Full Text] [Related]
18. Variability of glucose, insulin, and lipid disturbances in first-episode psychosis: a meta-analysis.
Pillinger T; McCutcheon RA; Howes OD
Psychol Med; 2023 May; 53(7):3150-3156. PubMed ID: 37449481
[TBL] [Abstract][Full Text] [Related]
19. Metabolic risk factors in drug-naive patients with first-episode psychosis.
Verma SK; Subramaniam M; Liew A; Poon LY
J Clin Psychiatry; 2009 Jul; 70(7):997-1000. PubMed ID: 19497246
[TBL] [Abstract][Full Text] [Related]
20. Relationship of hyperinsulinaemia, insulin resistance and β-cell dysfunction with incident diabetes and pre-diabetes: the Tehran Lipid and Glucose Study.
Derakhshan A; Tohidi M; Arshi B; Khalili D; Azizi F; Hadaegh F
Diabet Med; 2015 Jan; 32(1):24-32. PubMed ID: 25131451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
